Related Experiment Videos
Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies.
L Bubendorf1, A Nocito, H Moch
1Institute of Pathology, University of Basel, 4003 Basel, Switzerland.
The Journal of Pathology
|September 25, 2001
Summary
Tissue microarray (TMA) technology accelerates molecular and clinico-pathological studies by enabling in situ analysis of numerous tissue samples. Findings on TMAs are representative, speeding up research translation to clinical applications.
Area of Science:
- Biotechnology
- Pathology
- Molecular Biology
Background:
- Tissue microarray (TMA) technology enables high-throughput analysis of archival tissue samples.
- It facilitates the correlation of molecular findings with clinico-pathological information.
- TMAs are crucial for advancing tissue-based research.
Purpose of the Study:
- To highlight the efficiency and representativeness of TMA technology.
- To emphasize the role of TMAs in accelerating research.
- To promote the adoption of TMAs in molecular pathology.
Main Methods:
- Cylindrical tissue samples (0.6 mm diameter) are collected from up to 1000 archival blocks.
- Samples are embedded into a single recipient paraffin block.
- Sections are utilized for various in situ analyses like immunohistochemistry and in situ hybridization.
Main Results:
- TMA findings are highly representative of the original donor tissues.
- The technique allows for massive acceleration of studies correlating molecular and clinico-pathological data.
- TMAs enable rapid analysis of thousands of tumors.
Conclusions:
- Tissue microarray technology is a powerful tool for accelerating scientific discovery.
- TMAs significantly expedite the translation of basic research into clinical applications.
- Widespread adoption of TMAs is anticipated for all tissue-based research.